kind glp 1 patches review GLP-1 Review: Weight Loss or Wellness Hype? Kind Patches Review Do These
Description
The SURPASS-1 trial demonstrated significant improvements in glycemic control and substantial reductions in body weight with all three doses of tirzepatide (5 mg, 10 mg, or 15 mg) compared to placebo over a 40-week period
[DOI] [PubMed] [Google Scholar] 7.Sanyal A.J., Bedossa P., Fraessdorf M., Neff G.W., Lawitz E., Bugianesi E., Anstee Q.M., Hussain S.A., Newsome P.N., Ratziu V., et al
2023;46(Suppl 1):S14057
[1] Similar titration schedules are recommended for other GLP-1 agonists to help improve tolerability and adherence
Sip slowly over 30 minutes
and grant support from Novo Nordisk and Boehringer Ingelheim
